Theriva Biologics, Inc. Quarterly Net Cash Provided by (Used in) Operating Activities in USD from Q1 2011 to Q1 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Theriva Biologics, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2011 to Q1 2024.
- Theriva Biologics, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$4.88M, a 13% increase year-over-year.
- Theriva Biologics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$19M, a 0.45% increase from 2022.
- Theriva Biologics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$19.1M, a 48% decline from 2021.
- Theriva Biologics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$12.9M, a 5.93% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)